HLA-DR Antikörper
-
- Target Alle HLA-DR Produkte
- HLA-DR
-
Reaktivität
- Human, Pavian, Cynomolgus, Rhesusaffen
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HLA-DR Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS)
- Verwendungszweck
- Anti-HLA-DR Unconjugated Antibody
- Produktmerkmale
- The L243 reacts with human HLA-DR antigen which is expressed on B lymphocytes, monocytes, macrophages, activated T lymphocytes, activated natural killer (NK) lymphocytes, and human progenitor cells. HLA-DR is also present on thymic epithelium, B lymphocyte dependent areas of spleen and lymph node, and B cell lymphomas.
- Aufreinigung
- Purified
- Reinheit
- >95 %
- Güteklasse
- GMP Grade
- Immunogen
- Human B lymphocytes
- Klon
- L243
- Isotyp
- IgG2a, kappa
-
anti-HLA-DR (HLA-DR) antibody (FITC)
HLA-DR Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-12 FITC
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human FACS, WB, IHC, ISt, StM Wirt: Maus Monoclonal TAL 1B5 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human FACS, WB, IP Wirt: Maus Monoclonal MEM-12 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human, Hund, Non-Human Primate FACS, WB, IP, IHC (fro), IHC (p), ICC Wirt: Maus Monoclonal L243 unconjugated
anti-HLA-DR (HLA-DR) antibody (PE)HLA-DR Reaktivität: Human, Hund, Non-Human Primate FACS Wirt: Maus Monoclonal L243 PE
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human FACS, WB, IHC, IF, ISt, StM Wirt: Maus Monoclonal SPM289 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human FACS, IP Wirt: Maus Monoclonal HL-39 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reaktivität: Human, Hund, Non-Human Primate FACS, WB, IP, IHC (fro), IHC (p), ICC, Func Wirt: Maus Monoclonal L243 unconjugated
anti-HLA-DR (HLA-DR) antibody (PE)HLA-DR Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-12 PE
anti-HLA-DR (HLA-DR) antibody (APC)HLA-DR Reaktivität: Human FACS Wirt: Maus Monoclonal MEM-12 APC
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- PBS pH 7.2, 0.1 % (w/v) BSA, 0.09 % (w/v) sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
-
- Target
- HLA-DR
- Andere Bezeichnung
- HLA-DR (HLA-DR Produkte)
- Gen-ID
- 3122, 3123
- NCBI Accession
- NM_019111
- UniProt
- P01903
- Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-
